HFS
TVTX icon

Hughes Financial Services’s Travere Therapeutics TVTX Stock Holding History

Hughes Financial Services’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$57 Hold
1
– – ﹤0.01% 1571
2026
Q1 		$30 Buy
+1
New +$30 ﹤0.01% 1548

Other funds holding TVTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
BC
Burney Company Reston, Virginia $3.71B AUM 37.66% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
HCMT
Highland Capital Management (Tennessee) Memphis, Tennessee $2.17B AUM 54.74% 1-Year Est. Return
YMRC
Yorktown Management & Research Company Forest, Virginia $163M AUM 68.53% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Hughes Financial Services's TVTX Position: Q2 2026 in Review

Hughes Financial Services held its Travere Therapeutics (TVTX) position steady in Q2 2026 at 1 share worth $57. The position accounts for ﹤0.01% of the portfolio, ranked #1571.

Hughes Financial Services first reported a position in TVTX in Q1 2026 and has held it in 2 quarters since. 31 funds tracked by Wall St. Rank hold TVTX as of Q2 2026.

  • Hughes Financial Services held 1 share of Travere Therapeutics worth $57 as of Q2 2026.
  • Hughes Financial Services left its Travere Therapeutics share count unchanged in Q2 2026.
  • Travere Therapeutics made up ﹤0.01% of Hughes Financial Services's portfolio in Q2 2026, its #1571 holding.
  • Hughes Financial Services first reported a position in Travere Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 31 funds tracked by Wall St. Rank held Travere Therapeutics as of Q2 2026.

Based on Hughes Financial Services's 13F filing for Q2 2026, filed 20 Jul 2026.